This scientific visualization is much more than a dizzying dance of whirling worlds. It shows 2,299 planets found by NASA’s Kepler planet-hunting spacecraft.

The post Animation: Dizzying dance of the Kepler candidates appeared first on Smithsonian Insider.

For the first time, a new public database will link genetic data with records of where and when the samples it was taken from were […]

The post A first: New website reveals origin of genetic samples and date collected appeared first on Smithsonian Insider.

Corn, known also as maize, is a vital crop in the U.S. and throughout the Americas. First domesticated in Mexico some 9,000 years ago, scientists […]

The post Study dates corn as staple crop in Central America beginning 4,300 years ago appeared first on Smithsonian Insider.

In the structure of the title salt, second-order Jahn–Teller distortion of the coordination octa­hedra around V ions is reflected by coexistence of short V—O bonds and trans-positioned long V—F bonds, with four equatorial V—F distances being inter­mediate in magnitude. Hydrogen bonding of the anions is restricted to F-atom acceptors only, with particularly strong N–H⋯F inter­actions [N⋯F = 2.5072 (15) Å] established by axial and cis-positioned equatorial F atoms.

In a Model block, if the instance-specific value of a model argument has an anonymous structure type, an update diagram reports an error when there are multiple bus types that match that anonymous structure type.This bug exists in the following release(s):
R2020a

This bug has a workaround

Interested in Upgrading?

The GDC Compliance Advisory Board (CAB) provides insight into how to interpret the Strong Consumer Authentication (SCA) mandate described in PSD 2 without jeopardizing data privacy concerns protected by GDPR. 

In the structure of the title salt, (C7H12N6)[VOF5], second-order Jahn–Teller distortion of the coordination octahedra around V ions is reflected by coexistence of short V—O bonds [1.5767 (12) Å] and trans-positioned long V—F bonds [2.0981 (9) Å], with four equatorial V—F distances being intermediate in magnitude [1.7977 (9)–1.8913 (9) Å]. Hydrogen bonding of the anions is restricted to F-atom acceptors only, with particularly strong N–H...F interactions [N...F = 2.5072 (15) Å] established by axial and cis-positioned equatorial F atoms. Hirshfeld surface analysis indicates that the most important interactions are overwhelmingly H...F/F...H, accounting for 74.4 and 36.8% of the contacts for the individual anions and cations, respectively. Weak CH...F and CH...N bonds are essential for generation of three-dimensional structure.

Source: Streetwise Reports   05/06/2020

In a May 4 research note, H.C. Wainwright & Co. analyst Ed Arce reported that Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ) formed a partnership with Catalent Inc. (CTLT:NYSE), which "raises the profile of LUNAR-COV19 as a leading vaccine candidate."

Arce reviewed Catalent's contribution to the partnership. The global contract development and manufacturing organization is to manufacture Arcturus' messenger RNA (mRNA) LUNAR-COV19 for protection against SARS-CoV-2 to be used first for human clinical trials and potentially, eventually commercially.

As for timing, Arce noted, San Diego, Calif.-based Arcturus intends to transfer its vaccine technology to Catalent this month and expects Catalent to manufacture the first batches of LUNAR-COV19 by June 2020. "Critically, Arcturus continues to anticipate initiation of Phase 1 testing of LUNAR-COV19 in the summer of 2020," Arce highlighted.

Catalent is to produce the vaccine at its biomanufacturing facility in Madison, Wisc. "This facility utilizes Catalent's flex-suite, a current good manufacturing practice manufacturing suite, that can produce batches at multiple scales and support Arcturus' proprietary mRNA manufacturing process," explained Arce.

Obtaining the vaccine from one facility domestically versus multiple entities worldwide should result in several benefits, Arce continued. They include easy development and production, accelerated delivery and improved costs. Arcturus believes Catalent can produce millions of doses of LUNAR-COV19 mRNA in 2020 and, if need be, hundreds of millions of doses each year subsequently for use globally.

Arce pointed out that LUNAR-COV19 differentiates itself from other similar vaccine candidates in that the technology and delivery platform behind it deliver an "extraordinarily low dose (perhaps 2 micrograms)" in "a potential single shot."

H.C. Wainwright has a Buy rating and a $62 per share price target on Arcturus, the stock of which is currently trading at about $42.12 per share.

Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

Disclosures from H.C. Wainwright & Co., Arcturus Therapeutics Holdings Inc., First Take, May 4, 2020

Investment Banking Services include, but are not limited to, acting as a manager/co-manager in the underwriting or placement of securities, acting as financial advisor, and/or providing corporate finance or capital markets-related services to a company or one of its affiliates or subsidiaries within the past 12 months.

I, Ed Arce, certify that 1) all of the views expressed in this report accurately reflect my personal views about any and all subject securities or issuers discussed; and 2) no part of my compensation was, is, or will be directly or indirectly related to the specific recommendation or views expressed in this research report; and 3) neither myself nor any members of my household is an officer, director or advisory board member of these companies.

None of the research analysts or the research analyst's household has a financial interest in the securities of Arcturus Therapeutics Holdings Inc. (including, without limitation, any option, right, warrant, future, long or short position).

As of April 30, 2020 neither the Firm nor its affiliates beneficially own 1% or more of any class of common equity securities of Arcturus Therapeutics Holdings Inc.

Neither the research analyst nor the Firm has any material conflict of interest in of which the research analyst knows or has reason to know at the time of publication of this research report.

The research analyst principally responsible for preparation of the report does not receive compensation that is based upon any specific investment banking services or transaction but is compensated based on factors including total revenue and profitability of the Firm, a substantial portion of which is derived from investment banking services.

The firm or its affiliates received compensation from Arcturus Therapeutics Holdings Inc. for non-investment banking services in the previous 12 months.

The Firm or its affiliates did receive compensation from Arcturus Therapeutics Holdings Inc. for investment banking services within twelve months before, and will seek compensation from the companies mentioned in this report for investment banking services within three months following publication of the research report.

H.C. Wainwright & Co., LLC managed or co-managed a public offering of securities for Arcturus Therapeutics Holdings Inc. during the past 12 months.

The Firm does not make a market in Arcturus Therapeutics Holdings Inc. as of the date of this research report.

H.C. Wainwright & Co., LLC and its affiliates, officers, directors, and employees, excluding its analysts, will from time to time have long or short positions in, act as principal in, and buy or sell, the securities or derivatives (including options and warrants) thereof of covered companies referred to in this research report.

( Companies Mentioned: ARCT:NASDAQ, )

Government authorities in the United States and Canada should use the current Dietary Reference Intakes (DRIs) to update nutrition information on food and dietary supplement labels so that consumers can compare products more easily and make informed food choices based on the latest science, says a new report from the Institute of Medicine of the National Academies.

A growing amount of scientific evidence indicates that how much weight women gain during pregnancy and their starting weight at conception can affect their health and that of their babies, says a new report from the Institute of Medicine and the National Research Council.

The U.S. electric power delivery system is vulnerable to terrorist attacks that could cause much more damage to the system than natural disasters such as Hurricane Sandy, blacking out large regions of the country for weeks or months and costing many billions of dollars, says a newly released report by the National Research Council.

There would not be sufficient benefit to updating estimates of the social cost of carbon (SCC) within a year based only on the revision of a specific climate parameter in the existing framework used by the government’s interagency group to measure the SCC, says a new interim report from the National Academies of Sciences, Engineering, and Medicine.

The current process for planetary protection policy development is inadequate to respond to increasingly complex solar system exploration missions, says a new report from the National Academies of Sciences, Engineering, and Medicine.

A new report from the National Academies of Sciences, Engineering, and Medicine reviews current evidence and updates intake recommendations known as the Dietary Reference Intakes (DRIs) for sodium and potassium that were established in 2005.

Pictured: Larry broadcasting AirTalk from the Mantle household for the first time last Friday.; Credit: Larry Mantle/KPCC

Dear KPCC Listener,

I hope you and your family are staying safe and healthy during this pandemic. We’re doing well at the Mantle house, but with Kristen and our son Desmond working and studying at home, we’re experiencing some of the same daily logistical challenges you likely are. With that in mind, I’d like to update you on the dramatic changes that have occurred with AirTalk during this time of COVID-19.

Every day a noted medical expert is joining us to answer listener questions. It’s allowed us to stay on the cutting edge of COVID-19 and public health developments.

We’re also continuing to convene the largest conversation anywhere in Southern California, but with a new focus. Each day listeners are describing how they’re dealing with the coronavirus, whether staying at home or providing essential services to our community. We’ve heard from students studying online, truck drivers looking for open restrooms on the highway, restaurant owners and employees wondering when, or if, they’ll be able to reopen, and listeners living in their cars seeking a hotel room or shower. In 35 years of hosting AirTalk, I’ve never experienced a time of greater importance for bringing Angelenos together. It’s vital that we talk with - and hear from - each other as we meet this experience together.

This wasn’t how I’d anticipated the 35th anniversary month of AirTalk, but I’m deeply appreciative of the work our dedicated producers are doing while they work from home. A prime example came last week when a hospital emergency forced our physician guest to cancel shortly before airtime. Our producers leapt to action, quickly finding noted infectious disease specialist Dr. Peter Chin-Hong to step right in.

When we finished the live segment, I thanked Dr. Chin-Hong for dropping his important work at UCSF Medical Center to join us. He replied that it’s always a pleasure to speak to one of his favorite audiences.

I couldn’t agree more. KPCC listeners are deeply devoted, not just to their favorite programs, but to the irreplaceable mission of KPCC. We’ll do everything we can during this difficult time to serve that mission – by serving you. Thank you for giving us that opportunity.

Sincerely,
Larry Mantle
Host, AirTalk

P.S. KPCC has always been funded by listeners, and member support is truly critical at this time. With recent substantial losses of sponsor support related to the pandemic, every donation makes a tremendous impact for this vital public service. If you can, please make a gift today to sustain the journalism you and your community needs.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Source: Streetwise Reports   05/06/2020

In a May 4 research note, H.C. Wainwright & Co. analyst Ed Arce reported that Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ) formed a partnership with Catalent Inc. (CTLT:NYSE), which "raises the profile of LUNAR-COV19 as a leading vaccine candidate."

Arce reviewed Catalent's contribution to the partnership. The global contract development and manufacturing organization is to manufacture Arcturus' messenger RNA (mRNA) LUNAR-COV19 for protection against SARS-CoV-2 to be used first for human clinical trials and potentially, eventually commercially.

As for timing, Arce noted, San Diego, Calif.-based Arcturus intends to transfer its vaccine technology to Catalent this month and expects Catalent to manufacture the first batches of LUNAR-COV19 by June 2020. "Critically, Arcturus continues to anticipate initiation of Phase 1 testing of LUNAR-COV19 in the summer of 2020," Arce highlighted.

Catalent is to produce the vaccine at its biomanufacturing facility in Madison, Wisc. "This facility utilizes Catalent's flex-suite, a current good manufacturing practice manufacturing suite, that can produce batches at multiple scales and support Arcturus' proprietary mRNA manufacturing process," explained Arce.

Obtaining the vaccine from one facility domestically versus multiple entities worldwide should result in several benefits, Arce continued. They include easy development and production, accelerated delivery and improved costs. Arcturus believes Catalent can produce millions of doses of LUNAR-COV19 mRNA in 2020 and, if need be, hundreds of millions of doses each year subsequently for use globally.

Arce pointed out that LUNAR-COV19 differentiates itself from other similar vaccine candidates in that the technology and delivery platform behind it deliver an "extraordinarily low dose (perhaps 2 micrograms)" in "a potential single shot."

H.C. Wainwright has a Buy rating and a $62 per share price target on Arcturus, the stock of which is currently trading at about $42.12 per share.

Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

Disclosures from H.C. Wainwright & Co., Arcturus Therapeutics Holdings Inc., First Take, May 4, 2020

Investment Banking Services include, but are not limited to, acting as a manager/co-manager in the underwriting or placement of securities, acting as financial advisor, and/or providing corporate finance or capital markets-related services to a company or one of its affiliates or subsidiaries within the past 12 months.

I, Ed Arce, certify that 1) all of the views expressed in this report accurately reflect my personal views about any and all subject securities or issuers discussed; and 2) no part of my compensation was, is, or will be directly or indirectly related to the specific recommendation or views expressed in this research report; and 3) neither myself nor any members of my household is an officer, director or advisory board member of these companies.

None of the research analysts or the research analyst's household has a financial interest in the securities of Arcturus Therapeutics Holdings Inc. (including, without limitation, any option, right, warrant, future, long or short position).

As of April 30, 2020 neither the Firm nor its affiliates beneficially own 1% or more of any class of common equity securities of Arcturus Therapeutics Holdings Inc.

Neither the research analyst nor the Firm has any material conflict of interest in of which the research analyst knows or has reason to know at the time of publication of this research report.

The research analyst principally responsible for preparation of the report does not receive compensation that is based upon any specific investment banking services or transaction but is compensated based on factors including total revenue and profitability of the Firm, a substantial portion of which is derived from investment banking services.

The firm or its affiliates received compensation from Arcturus Therapeutics Holdings Inc. for non-investment banking services in the previous 12 months.

The Firm or its affiliates did receive compensation from Arcturus Therapeutics Holdings Inc. for investment banking services within twelve months before, and will seek compensation from the companies mentioned in this report for investment banking services within three months following publication of the research report.

H.C. Wainwright & Co., LLC managed or co-managed a public offering of securities for Arcturus Therapeutics Holdings Inc. during the past 12 months.

The Firm does not make a market in Arcturus Therapeutics Holdings Inc. as of the date of this research report.

H.C. Wainwright & Co., LLC and its affiliates, officers, directors, and employees, excluding its analysts, will from time to time have long or short positions in, act as principal in, and buy or sell, the securities or derivatives (including options and warrants) thereof of covered companies referred to in this research report.

( Companies Mentioned: ARCT:NASDAQ, )

A research update on climate change has indicated that many global risks are now assessed as stronger than predicted by the 2007 IPCC Fourth Assessment Report (AR4). The risk of large sea-level rise, extreme weather events and ocean acidification are all thought to be underestimated by the AR4.

Direct messages on the desktop have been in the works for a while now.

Today I'd like to introduce a guest blogger, Stephen Doe, who works for the MATLAB Documentation team here at MathWorks. In today's post, Stephen discusses how to take advantage of recent performance improvements when indexing into tables. The same approach applies to many different data types. While the release notes describe the performance improvements, in today's post Stephen also offers further advice based on a simple code example.... read more >>

Someone recently challenged me to convert the curling simulator we published a few years ago (See this post and this post) to take advantage of new features not available at that time: App Designer and Stateflow for MATLAB.... read more >>

The most up-to-date knowledge and data must be used to assess policy objectives, new research confirms. Studying air pollution environmental quality targets set by the National Emission Ceilings (NEC) Directive1, a new study has shown that if 2001 data are used to assess progress, most such targets appear to have been met. However, more recent and accurate current data show that this may not be the case.

FREDERICKSBURG , Va. – An additional evening of work is required this week for an ongoing pin replacement on the Robert O. Norris Bridge, and...

FREDERICKSBURG, Va. – All lanes are now open on Route 1 at Austin Park Drive in Stafford. An early morning crash closed Route 1 southbound and...

South Chesterfield – Virginia Department of Transportation crews continue recovery operations from the impacts of Tropical Storm Michael....

South Chesterfield – Approximately 100 roads in the Virginia Department of Transportation’s Richmond District have reopened as crews continue...

South Chesterfield – More than 150 roads in the Virginia Department of Transportation’s Richmond District have reopened as crews continue recovery...

South Chesterfield – After repairing and reopening approximately 200 roads in the region, Virginia Department of Transportation crews are shifting...

LYNCHBURG —What a difference a day makes. At least as far as the weather is concerned. The heavy rain and strong winds from yesterday have given way to sunny skies and a calm breeze. Unfortunately, Tropical Storm Michael’s aftermath remains a reminder.

LYNCHBURG —(10 a.m.) Road conditions continue to improve across the Lynchburg District; however, approximately 130 roads remain closed as a result of weather from Tropical Storm Michael.

LYNCHBURG —Over a week after the rain and wind of Tropical Storm Michael took aim on the Commonwealth, the Virginia Department of Transportation continues to assess roads and bridges in the Lynchburg District affected by the storm. By the time Michael exited the area, over 220 road and 360 structures were under water and as of today (Friday, October 19) only six short-term closures, in addition to the long-term closures below, remain.

LYNCHBURG, Va. – US 58 over Sandy Creek at the Halifax/Pittsylvania County line has been closed to traffic since Tropical Storm Michael struck the Commonwealth in October and motorists have used a lengthy detour that required travel in North Carolina. Weather permitting the eastbound structure will re-open to one lane of traffic in each direction today, Wednesday, November 7.

This file is in PDF format, requiring the Adobe Acrobat Reader to open.

This file is in PDF format, requiring the Adobe Acrobat Reader to open.

000
WTPZ65 KNHC 210437
TCUEP5

Hurricane Lorena Tropical Cyclone Update
NWS National Hurricane Center Miami FL EP152019
1035 PM MDT Fri Sep 20 2019

...LORENA MAKES LANDFALL NEAR LA VENTANA MEXICO IN SOUTHEASTERN BAJA
CALIFORNIA SUR...

Satellite images and surface observations indicate that Hurricane
Lorena made landfall near La Ventana, Mexico, in the state of Baja
California Sur around 0400 UTC (10 pm MDT) with maximum winds of 80
mph (130 km/h).

SUMMARY OF 1035 PM MDT...0435 UTC...INFORMATION
----------------------------------------------
LOCATION...24.0N 110.0W
ABOUT 25 MI...40 KM SE OF LA PAZ MEXICO
ABOUT 75 MI...125 KM N OF CABO SAN LUCAS MEXICO
MAXIMUM SUSTAINED WINDS...80 MPH...130 KM/H
PRESENT MOVEMENT...NNW OR 330 DEGREES AT 8 MPH...13 KM/H
MINIMUM CENTRAL PRESSURE...986 MB...29.12 INCHES

$$
Forecaster Cangialosi

000
WTNT61 KNHC 171827
TCUAT1

Tropical Storm Imelda Tropical Cyclone Update
NWS National Hurricane Center Miami FL AL112019
130 PM CDT Tue Sep 17 2019

...TROPICAL STORM IMELDA MAKES LANDFALL NEAR FREEPORT TEXAS...
...HEAVY RAINFALL AND THREAT OF FLASH FLOODING WILL SPREAD INLAND...

NOAA Doppler radar data and surface observations indicate that
Tropical Storm Imelda made landfall near Freeport, Texas at
100 PM CDT with maximum sustained winds of 40 mph.

A National Ocean Service observing site at Freeport, Texas reported
a minimum pressure near 1005 mb (29.68 inches) around the time of
landfall.

SUMMARY OF 130 PM CDT...1830 UTC...INFORMATION
---------------------------------------------------
LOCATION...29.0N 95.3W
ABOUT 0 MI...0 KM S OF FREEPORT TEXAS
ABOUT 35 MI...55 KM SW OF GALVESTON TEXAS
MAXIMUM SUSTAINED WINDS...40 MPH...65 KM/H
PRESENT MOVEMENT...N OR 5 DEGREES AT 7 MPH...11 KM/H
MINIMUM CENTRAL PRESSURE...1005 MB...29.68 INCHES

$$
Forecaster Zelinsky/Brown

000
WTPZ63 KNHC 150036 CCA
TCUEP3

Hurricane Kiko Tropical Cyclone Update...Corrected
NWS National Hurricane Center Miami FL EP132019
530 PM PDT Sat Sep 14 2019

Corrected location coordinates

...HURRICANE KIKO NEAR MAJOR HURRICANE STRENGTH...

Recent satellite-based intensity estimates indicate that Hurricane
Kiko has rapidly strengthened since the last advisory. The maximum
sustained winds have increased to 110 mph (175 km/h). The higher
intensity will be reflected in the next forecast advisory, which
will be issued before 800 PM PDT.


SUMMARY OF 530 PM AST...0030 UTC...INFORMATION
----------------------------------------------
LOCATION...17.0N 119.7W
ABOUT 760 MI...1225 KM WSW OF THE SOUTHERN TIP OF BAJA CALIFORNIA
MAXIMUM SUSTAINED WINDS...110 MPH...175 KM/H
PRESENT MOVEMENT...W OR 270 DEGREES AT 12 MPH...19 KM/H
MINIMUM CENTRAL PRESSURE...970 MB...28.64 INCHES

$$
Forecaster Zelinsky

000
WTNT62 KNHC 222359
TCUAT2

Tropical Storm Karen Tropical Cyclone Update
NWS National Hurricane Center Miami FL AL122019
800 PM AST Sun Sep 22 2019

...TROPICAL STORM WARNING DISCONTINUED FOR ST. VINCENT AND THE
GRENADINES...

The government of Barbados has discontinued the Tropical Storm
Warning for St. Vincent and the Grenadines.

$$
Forecaster Beven

000
WTNT63 KNHC 290207
TCUAT3

Hurricane Lorenzo Tropical Cyclone Update
NWS National Hurricane Center Miami FL AL132019
1010 PM AST Sat Sep 28 2019


...LORENZO STRENGTHENS INTO A CATEGORY 5 HURRICANE...

Recent satellite data indicate that Lorenzo has continued to
rapidly strengthen to an extremely dangerous category 5 hurricane
with maximum sustained winds near 160 mph (260 km/h). This
increase in intensity will be reflected in the forecast issued at
11 pm AST (0300 UTC).


SUMMARY OF 1010 PM AST...0210 UTC...INFORMATION
----------------------------------------------
LOCATION...24.1N 45.0W
ABOUT 1410 MI...2270 KM SW OF THE AZORES
MAXIMUM SUSTAINED WINDS...160 MPH...260 KM/H
PRESENT MOVEMENT...N OR 360 DEGREES AT 10 MPH...17 KM/H
MINIMUM CENTRAL PRESSURE...925 MB...27.31 INCHES

$$
Forecaster Brown/Latto

000
WTPZ61 KNHC 291316
TCUEP1

Tropical Storm Narda Tropical Cyclone Update
NWS National Hurricane Center Miami FL EP162019
915 AM CDT Sun Sep 29 2019

...CENTER OF NARDA NOW NEAR THE COAST OF MEXICO...

Satellite imagery and data from coastal stations in Mexico indicate
that the center of Narda is northwest of the previous advisory
position and it is now located close to the coast of Mexico near
Zihuatanejo. The Mexican Navy station at Puerto Vicente recently
reported sustained winds of 38 mph (62 km/h) and a wind gust of 52
mph (84 km/h).


SUMMARY OF 915 AM CDT...1315 UTC...INFORMATION
----------------------------------------------
LOCATION...17.6N 101.7W
ABOUT 15 MI...25 KM W OF ZIHUATANEJO MEXICO
MAXIMUM SUSTAINED WINDS...45 MPH...75 KM/H
PRESENT MOVEMENT...NW OR 325 DEGREES AT 15 MPH...24 KM/H
MINIMUM CENTRAL PRESSURE...998 MB...29.47 INCHES

$$
Forecaster Beven